MedTrace Logo

Drug Use Investigation for PAXIL Tablet

NCT01371435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3708

Last updated 2017-06-08

No results posted yet for this study

Summary

This post-marketing surveillance study is designed to detect adverse events (particularly clinically significant adverse drug reactions) occurring in clinical settings and to examine factors likely to affect the safety and efficacy of paroxetine.

Conditions

  • Mental Disorders

Interventions

DRUG

Paroxetine

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2005-09-30
Completion
2005-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01371435 on ClinicalTrials.gov